A new immunization to protect infants from respiratory syncytial virus, or RSV, has been approved by the CDC.
This illustration provided by AstraZeneca depicts packaging for their medication Beyfortus.was approved by the Centers for Disease Control and Prevention on Thursday.
It comes less than two weeks after the Food and Drug Administration approved the shot, with both federal agencies saying it's safe and effective at protecting infants against the risk of severe infection and hospitalization from RSV.Beyfortus is a one-dose shot made of monoclonal antibodies, which are proteins manufactured in a lab and mimic the antibodies the body naturally creates when fighting an infection.
In addition, the advisory committee also passed a resolution to add this shot to the federally funded Vaccine for Children program that ensures children on Medicaid or those under and uninsured can receive the drug at no cost.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Babies should get new drug that prevents RSV, CDC panel saysInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, heath advisers recommended Thursday.
Baca lebih lajut »
Babies should get new drug that prevents RSV, CDC panel saysInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, health advisers recommended Thursday.
Baca lebih lajut »
CDC advisers vote to recommend new preventive RSV shot for all infants | CNNAll infants under 8 months of age should get a new antibody shot to protect against hospitalization with respiratory syncytial virus, or RSV, according to a panel of independent experts that advises the United States Centers for Disease Control and Prevention on its immunization recommendations.
Baca lebih lajut »
Babies Should Get New Drug That Prevents RSV, CDC Panel SaysAn infection with RSV is a cold-like nuisance for most healthy people, but it can be life-threatening for the very young and the elderly. There are no vaccines for babies, so the new drug is expected to fill a critical need.
Baca lebih lajut »
CDC panel says babies should get new drug that prevents RSVInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, heath...
Baca lebih lajut »